Literature DB >> 26244063

3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?

Rossano Girometti1.   

Abstract

An ever-increasing number of 3.0 Tesla (T) magnets are installed worldwide. Moving from the standard of 1.5 T to higher field strength implies a number of potential advantage and drawbacks, requiring careful optimization of imaging protocols or implementation of novel hardware components. Clinical practice and literature review suggest that state-of-the-art 3.0 T is equivalent to 1.5 T in the assessment of focal liver lesions and diffuse liver disease. Therefore, further technical improvements are needed in order to fully exploit the potential of higher field strength.

Entities:  

Keywords:  1.5 Tesla; 3.0 Tesla; Liver; Magnetic field strength; Magnetic resonance imaging

Year:  2015        PMID: 26244063      PMCID: PMC4517148          DOI: 10.4254/wjh.v7.i15.1894

Source DB:  PubMed          Journal:  World J Hepatol


  35 in total

1.  Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content.

Authors:  Jochem R van Werven; Johannes M Hoogduin; Aart J Nederveen; Andre A van Vliet; Ewa Wajs; Petra Vandenberk; Erik S G Stroes; Jaap Stoker
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

2.  Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease.

Authors:  Masakatsu Tsurusaki; Richard C Semelka; Mauricio Zapparoli; Jorge Elias; Ersan Altun; Ertan Pamuklar; Kazuro Sugimura
Journal:  Eur J Radiol       Date:  2008-09-13       Impact factor: 3.528

3.  Diffusion-weighted imaging of the abdomen at 3 T: image quality comparison with 1.5-T magnet using 3 different imaging sequences.

Authors:  Farhood Saremi; Mehdi Jalili; Sepideh Sefidbakht; Stephanie Channual; Lisa Quane; Nassim Naderi; Helmuth Schultze-Haakh; Maria Torrone
Journal:  J Comput Assist Tomogr       Date:  2011 May-Jun       Impact factor: 1.826

4.  Liver MRI at 3.0 tesla: comparison of image quality and lesion detectability between single-source conventional and dual-source parallel radiofrequency transmissions.

Authors:  Jiyoung Hwang; Young Kon Kim; Min Jung Park; Mi Hee Lee; Seong Hyun Kim; Won Jae Lee; Dongil Choi
Journal:  J Comput Assist Tomogr       Date:  2012 Sep-Oct       Impact factor: 1.826

5.  Gadoxetic acid-enhanced fat suppressed three-dimensional T1-weighted MRI using a multiecho dixon technique at 3 tesla: emphasis on image quality and hepatocellular carcinoma detection.

Authors:  Mi Hee Lee; Young Kon Kim; Min Jung Park; Jiyoung Hwang; Seong Hyun Kim; Won Jae Lee; Dongil Choi
Journal:  J Magn Reson Imaging       Date:  2013-01-04       Impact factor: 4.813

6.  High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T.

Authors:  Marcus M von Falkenhausen; Götz Lutterbey; Nuschin Morakkabati-Spitz; Oliver Walter; Jürgen Gieseke; Renate Blömer; Winfried A Willinek; Hans H Schild; Christiane K Kuhl
Journal:  Radiology       Date:  2006-08-14       Impact factor: 11.105

7.  Focal liver lesions at 3.0 T: lesion detectability and image quality with T2-weighted imaging by using conventional and dual-source parallel radiofrequency transmission.

Authors:  Guido M Kukuk; Jürgen Gieseke; Sebastian Weber; Dariusch R Hadizadeh; Michael Nelles; Frank Träber; Hans H Schild; Winfried A Willinek
Journal:  Radiology       Date:  2011-02-17       Impact factor: 11.105

8.  Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.

Authors:  Hee Jin Kim; Bong Soo Kim; Mi Jeong Kim; Seong Hyun Kim; Rafael O P de Campos; Mateus Hernandes; Richard C Semelka
Journal:  J Magn Reson Imaging       Date:  2012-10-12       Impact factor: 4.813

9.  Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Authors:  Seong Hyun Kim; Seung Hoon Kim; Jongmee Lee; Min Ju Kim; Yong Hwan Jeon; Yulri Park; Dongil Choi; Won Jae Lee; Hyo K Lim
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

10.  Comparison of breathhold, navigator-triggered, and free-breathing diffusion-weighted MRI for focal hepatic lesions.

Authors:  Ji Soo Choi; Myeong-Jin Kim; Yong Eun Chung; Kyung Ah Kim; Jin-Young Choi; Joon Seok Lim; Mi-Suk Park; Ki Whang Kim
Journal:  J Magn Reson Imaging       Date:  2012-11-27       Impact factor: 4.813

View more
  3 in total

Review 1.  3 T: the good, the bad and the ugly.

Authors:  Martin John Graves
Journal:  Br J Radiol       Date:  2021-11-10       Impact factor: 3.039

2.  Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI.

Authors:  Lan Qiong; Zhao Jie; Zheng Zhong; Sheng Wen; Zhao Jun; Lu Liping; Cheng Jinkui
Journal:  BMJ Open       Date:  2022-02-17       Impact factor: 2.692

3.  Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC.

Authors:  François Willemssen; Quido de Lussanet de la Sablonière; Daniel Bos; Jan IJzermans; Robert De Man; Roy Dwarkasing
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.